73 related articles for article (PubMed ID: 2549130)
1. Control of therapy with microcirculatory and phlebotropically active drugs in patients with congenital and acquired venous insufficiency.
Wenzel E; Birkel L; Scheffler P; Waldhausen P; Jung F
Int Angiol; 1989; 8(1):41-6. PubMed ID: 2549130
[TBL] [Abstract][Full Text] [Related]
2. [Venous tonus-modifying effect, pharmacokinetics and undesired effects of dihydroergotamine].
Barthel W
Z Gesamte Inn Med; 1984 Sep; 39(17):417-28. PubMed ID: 6390997
[TBL] [Abstract][Full Text] [Related]
3. [Action of dihydroergotamine in venous insufficiency of the lower extremities. A clinico-instrumental study].
Marastoni F; Crespi B; Montorsi M; De Stefano A
Arch Sci Med (Torino); 1982; 139(2):165-74. PubMed ID: 6753796
[TBL] [Abstract][Full Text] [Related]
4. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.
Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162
[TBL] [Abstract][Full Text] [Related]
5. [Non-invasive methods in the study of hemodynamics of Klippel-Trenaunay syndrome].
Aelvoet G; Colemont L
Phlebologie; 1989; 42(4):609-15. PubMed ID: 2560550
[TBL] [Abstract][Full Text] [Related]
6. [The microcirculatory activity of Centella asiatica in venous insufficiency. A double-blind study].
Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Grimaldi R; Marelli C; Belcaro G
Minerva Cardioangiol; 1994 Jun; 42(6):299-304. PubMed ID: 7936334
[TBL] [Abstract][Full Text] [Related]
7. [Thromboembolic disease and congenital venous abnormalities].
Baskerville PA
Phlebologie; 1987; 40(2):531-6. PubMed ID: 3039545
[TBL] [Abstract][Full Text] [Related]
8. Rapid relief of signs/symptoms in chronic venous microangiopathy with pycnogenol: a prospective, controlled study.
Cesarone MR; Belcaro G; Rohdewald P; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M
Angiology; 2006; 57(5):569-76. PubMed ID: 17067979
[TBL] [Abstract][Full Text] [Related]
9. [DHE and venous insufficiency].
Hickel M
Phlebologie; 1979; 32(3):309-14. PubMed ID: 493369
[No Abstract] [Full Text] [Related]
10. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
[TBL] [Abstract][Full Text] [Related]
11. [Effect of dihydroergotamine on venous macro- and microcirculation in patients with healthy veins and in patients with chronic venous insufficiency].
Birkel L; Scheffler P; Jung F
Vasa Suppl; 1988; 23():253-6. PubMed ID: 3206341
[No Abstract] [Full Text] [Related]
12. Improvement of microcirculation and healing of venous hypertension and ulcers with Crystacide: evaluation with a microcirculatory model, including free radicals, laser doppler flux, and PO2/PCO2 measurements.
Belcaro G; Cesarone MR; Errichi BM; Di Renzo A; Errichi S; Ricci A; Gizzi G; Dugall M; Cacchio M; Ruffini I; Fano F; Vinciguerra G; Grossi MG
Angiology; 2007; 58(3):323-8. PubMed ID: 17626987
[TBL] [Abstract][Full Text] [Related]
13. [Dihydroergotamine in the treatment of patients with symptomatic hypotension during regular hemodialysis].
Milutinović S
Arzneimittelforschung; 1987 May; 37(5):554-6. PubMed ID: 3304301
[TBL] [Abstract][Full Text] [Related]
14. Safety and pharmacokinetics of dihydroergotamine mesylate administered via a Novel (Tempo) inhaler.
Shrewsbury SB; Cook RO; Taylor G; Edwards C; Ramadan NM
Headache; 2008 Mar; 48(3):355-67. PubMed ID: 18179563
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings.
Unkauf M; Rehn D; Klinger J; de la Motte S; Grossmann K
Arzneimittelforschung; 1996 May; 46(5):478-82. PubMed ID: 8737630
[TBL] [Abstract][Full Text] [Related]
16. [Management of chronic venous insufficiency with the combination of coumarin (Syncoumar) and oral pentosan polysulfate (PPS, SP 54) (preliminary report)].
Losonczy H; Nagy I; Menyhei G
Orv Hetil; 1993 Feb; 134(6):291-5. PubMed ID: 7679212
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
Andreozzi GM
Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of clinical efficacy of a venotonic drug: lessons of a therapeutic trial with hemisynthesis diosmin in "heavy legs syndrome"].
Carpentier PH; Mathieu M
J Mal Vasc; 1998 Apr; 23(2):106-12. PubMed ID: 9608923
[TBL] [Abstract][Full Text] [Related]
19. Microcirculatory dysfunction in chronic venous insufficiency (CVI).
Jünger M; Steins A; Hahn M; Häfner HM
Microcirculation; 2000; 7(6 Pt 2):S3-12. PubMed ID: 11151969
[TBL] [Abstract][Full Text] [Related]
20. Microcirculatory effects of Viatromb spray gel heparin in chronic venous insufficiency: evaluation of TcPO2 and PCO2--a product evaluation study.
Rosaria Cesarone M; Belcaro G; Errichi S; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M
Angiology; 2007; 58 Suppl 1():21S-26S. PubMed ID: 17478879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
